ONO-4578-04:ONO-4578 Phase 1 Study
Phase 1
- Conditions
- metastatic pancreatic cancer
- Registration Number
- JPRN-jRCT2031200286
- Lead Sponsor
- Hirashima Yoshinori
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
1. Pancreatic invasive ducatal adenocarcinoma
2. Life expectancy of at least 3 months
3. Patients with ECOG performance status 0 or 1
Exclusion Criteria
1. Patients with severe complication
2. Patients with multiple primary cancers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety, tolerability
- Secondary Outcome Measures
Name Time Method